ECM重构青春“土壤”：美柏生物以ECM人胶原引领再生医美新浪潮的底层逻辑

美柏生物ECM人胶原重塑细胞家园的底层逻辑与实践

科技护肤时代来临，重组人胶原引领再生抗衰新潮流

随着再生医学的蓬勃发展及生物科技的不断突破，市场逐渐从1.0自然护肤时代、2.0功效护肤时代进入到3.0科技护肤新时代。

年产80万支产能近10亿，美柏生物ECM创新工厂盛大落成

科研新闻 | 美柏生物首席科学家魏强教授团队在国际生物顶刊《Nature Communications》发布最新研究成果

美柏生物再添科研新成果，让再生如愿而生

最新News！美柏生物“2025年湖南省重点研发计划项目”立项

近日，美柏生物获批参与2025年湖南省重点研发计划项目——“负载生物制剂的智能释药系统治疗牙周炎关键技术研究及应用”（项目编号2025JK2124）

科研再突破！美柏生物参与“国家重点研发项目”！

\x26amp;nbsp; \x26amp;nbsp; \x26amp;nbsp; 近日，美柏生物获批参与国家重点研发计划项目 ——“生物适配型口腔抑

Maybio Biotech – Focusing on the Blue Ocean Upstream of Medical Aesthetics, a New Pioneer in Human-Derived ECM Composite Collagen

Maybio Biotech is an innovative enterprise focused on the R&D, production, and sales of medical aesthetic-related products. It is also China's first enterprise to efficiently produce human-derived ECM composite collagen using in vitro tissue engineering technology, having now achieved scaled mass production.

The research team led by Professor Wei Qiang, Chief Scientist of Maybio, Publishes Latest Research Findings in Global Top Stem Cell Journal Cell Stem Cell

Professor Wei Qiang, Chief Scientist at Maybio, and his research team, in collaboration with Professor Cao Yi's team from Nanjing University, releases: "Photo-tunable hydrogels reveal cellular sensing of rapid rigidity changes through the accumulation of mechanical signaling molecules"